Pharmx Technologies Ltd

Pharmx Technologies Ltd has a strong liquidity position, with a current ratio of 3.33, indicating the company can cover its short-term liabilities more than three times over. The company holds AUD 4.17 million in cash and equivalents, while its total liabilities amount to AUD 2.90 million. The debt-to-equity ratio is 0.06, suggesting a conservative capital structure with minimal reliance on debt financing. Despite its strong liquidity, Pharmx Technologies Ltd is currently unprofitable, with a net loss of AUD 264,000 and an operating loss of AUD 100,000 in the latest reporting period. The return on equity is -1.66%, and the return on assets is -1.4%, both significantly below the industry median for Online Services, which typically shows positive returns. The company's gross profit margin is 81.4%, but this is not sufficient to offset its operating and net losses. Pharmx Technologies Ltd operates as a single-segment entity, with all revenue derived from its core software and IT services for the pharmaceutical and healthcare industries. The company does not disclose geographic revenue breakdowns, but its operations are primarily based in Australia, with no material international exposure reported in the latest financials. The company's growth trajectory is uncertain, with no clear revenue growth in the latest period. Revenue for the period was AUD 7.32 million, with no prior period data provided for comparison. The outlook for the current fiscal year is neutral, with no significant changes expected in the near term. The company's capital expenditures were AUD 1.75 million, primarily used for IT infrastructure and platform development. Pharmx Technologies Ltd faces low liquidity and dilution risk, with no immediate filing-based flags detected. The company has a low probability of near-term dilution, with no recent share issuance or shelf registration activity reported. The dilution potential is minimal, as the number of basic and diluted shares outstanding is identical at 659.46 million. The company's operating cash flow is negative at AUD 8.13 million, but this is offset by its strong cash reserves. Recent events include the filing of its latest financial report, which disclosed the operating and net losses, as well as the capital expenditures. No material legal or regulatory actions were reported in the latest filings. The company has not issued any new products or services in the recent period, and no major strategic shifts were disclosed.